Profound Medical
(NASDAQ) PROF
Profound Medical Financials at a Glance
Market Cap
$247.46M
Revenue (TTM)
$18.87M
Net Income (TTM)
-$39.20M
EPS (TTM)
-$1.25
P/E Ratio
-5.46
Dividend
$0.00
Beta (Volatility)
1.09 (Average)
Dividend
$0.00
Beta (Volatility)
1.09 (Average)
Price
$6.77
Volume
28,271.899
Open
$6.89
Price
$6.77
Volume
28,271.899
Open
$6.89
Previous Close
$6.81
Daily Range
$6.75 - $6.93
52-Week Range
$3.76 - $8.95
Dividend
$0.00
Beta (Volatility)
1.09 (Average)
Price
$6.77
Volume
28,271.899
Open
$6.89
Previous Close
$6.81
Daily Range
$6.75 - $6.93
52-Week Range
$3.76 - $8.95
PROF News
PROF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Profound Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
162
CEO
Arun S. Menawat, PhD, EMBA
Website
www.profoundmedical.comHeadquarters
Mississauga, ON L4W 5K5, CA
PROF Financials
Key Financial Metrics (TTM)
Gross Margin
71%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-71%
Return on Capital
-65%
Return on Assets
-57%
Earnings Yield
-18.32%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$247.46M
Shares Outstanding
36.34M
Volume
28.27K
Avg. Volume
182.81K
Financials (TTM)
Gross Profit
$11.59M
Operating Income
-$41.98M
EBITDA
-$41.41M
Operating Cash Flow
-$53.34M
Capital Expenditure
-$245.73K
Free Cash Flow
-$53.59M
Cash & ST Invst.
$81.80M
Total Debt
$6.45M
Profound Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$5.26M
+101.4%
Gross Profit
$3.78M
+104.6%
Gross Margin
71.80%
N/A
Market Cap
$247.46M
N/A
Market Cap/Employee
$1.74M
N/A
Employees
142
N/A
Net Income
-$6.96M
+34.9%
EBITDA
-$7.81M
+28.8%
Quarterly Fundamentals
Net Cash
$42.97M
+3.4%
Accounts Receivable
$9.45M
+58.5%
Inventory
$9.03M
+32.9%
Long Term Debt
$2.90M
-37.2%
Short Term Debt
$4.59M
+1657.1%
Return on Assets
-57.03%
N/A
Return on Invested Capital
-64.85%
N/A
Free Cash Flow
-$8.58M
-3.6%
Operating Cash Flow
-$8.58M
-3.6%